Personal information

United States

Activities

Works (50 of 108)

Items per page:
Page 1 of 3

PET-Assessed Metabolic Tumor Volume Across the Spectrum of Solid-Organ Malignancies: A Review of the Literature

Biomedicines
2025-01-07 | Journal article
Contributors: Anusha Agarwal; Chase J. Wehrle; Sangeeta Satish; Paresh Mahajan; Suneel Kamath; Shlomo Koyfman; Wen Wee Ma; Maureen Linganna; Jamak Modaresi Esfeh; Charles Miller et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Advancing Cholangiocarcinoma Care: Insights and Innovations in T Cell Therapy

Cancers
2024-09-23 | Journal article
Contributors: Neda Dadgar; Arun K. Arunachalam; Hanna Hong; Yee Peng Phoon; Jorge E. Arpi-Palacios; Melis Uysal; Chase J. Wehrle; Federico Aucejo; Wen Wee Ma; Jan Joseph Melenhorst
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The Impact of Biliary Injury on the Recurrence of Biliary Cancer and Benign Disease after Liver Transplantation: Risk Factors and Mechanisms

Cancers
2024-08 | Journal article | Author
Contributors: Chase Wehrle; Rebecca Panconesi; Sangeeta Satish; Marianna Maspero; Chunbao Jiao; Keyue Sun; Omer Karakaya; Erlind Allkushi; Jamak Modaresi Esfeh ; Maureen Whitsett Linganna et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Data from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Data from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

Clinical Cancer Research
2024-04-01 | Journal article
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S10 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S10 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S11 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S11 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S6 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S6 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S7 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S7 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S8 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S8 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S9 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Figure S9 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Methods 1 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Methods 1 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Table S1 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Table S1 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Table S2 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Table S2 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Table S3 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Table S3 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Table S4 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Table S4 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Table S5 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Table S5 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Table S6 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Supplementary Table S6 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

2024-04-01 | Preprint
Contributors: Tista Roy Chaudhuri; Qingxiang Lin; Ewa K. Stachowiak; Spencer R. Rosario; Joseph A. Spernyak; Wen Wee Ma; Michal K. Stachowiak; Michelle K. Greene; Gerard P. Quinn; Simon S. McDade et al.
Source: check_circle
Crossref

Data from Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies

2024-02-01 | Preprint
Contributors: Benedito A. Carneiro; Ludimila Cavalcante; Devalingam Mahalingam; Anwaar Saeed; Howard Safran; Wen Wee Ma; Andrew L. Coveler; Steven Powell; Bruno Bastos; Elizabeth Davis et al.
Source: check_circle
Crossref

Data from Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies

2024-02-01 | Preprint
Contributors: Benedito A. Carneiro; Ludimila Cavalcante; Devalingam Mahalingam; Anwaar Saeed; Howard Safran; Wen Wee Ma; Andrew L. Coveler; Steven Powell; Bruno Bastos; Elizabeth Davis et al.
Source: check_circle
Crossref

Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies

Clinical Cancer Research
2024-02-01 | Journal article
Contributors: Benedito A. Carneiro; Ludimila Cavalcante; Devalingam Mahalingam; Anwaar Saeed; Howard Safran; Wen Wee Ma; Andrew L. Coveler; Steven Powell; Bruno Bastos; Elizabeth Davis et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies

2024-02-01 | Preprint
Contributors: Benedito A. Carneiro; Ludimila Cavalcante; Devalingam Mahalingam; Anwaar Saeed; Howard Safran; Wen Wee Ma; Andrew L. Coveler; Steven Powell; Bruno Bastos; Elizabeth Davis et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies

2024-02-01 | Preprint
Contributors: Benedito A. Carneiro; Ludimila Cavalcante; Devalingam Mahalingam; Anwaar Saeed; Howard Safran; Wen Wee Ma; Andrew L. Coveler; Steven Powell; Bruno Bastos; Elizabeth Davis et al.
Source: check_circle
Crossref

Supplementary Figure S10 from Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies

2024-02-01 | Preprint
Contributors: Benedito A. Carneiro; Ludimila Cavalcante; Devalingam Mahalingam; Anwaar Saeed; Howard Safran; Wen Wee Ma; Andrew L. Coveler; Steven Powell; Bruno Bastos; Elizabeth Davis et al.
Source: check_circle
Crossref

Supplementary Figure S10 from Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies

2024-02-01 | Preprint
Contributors: Benedito A. Carneiro; Ludimila Cavalcante; Devalingam Mahalingam; Anwaar Saeed; Howard Safran; Wen Wee Ma; Andrew L. Coveler; Steven Powell; Bruno Bastos; Elizabeth Davis et al.
Source: check_circle
Crossref

Supplementary Figure S11 from Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies

2024-02-01 | Preprint
Contributors: Benedito A. Carneiro; Ludimila Cavalcante; Devalingam Mahalingam; Anwaar Saeed; Howard Safran; Wen Wee Ma; Andrew L. Coveler; Steven Powell; Bruno Bastos; Elizabeth Davis et al.
Source: check_circle
Crossref
Items per page:
Page 1 of 3

Peer review (1 review for 1 publication/grant)

Review activity for npj genomic medicine. (1)